SCHEMBL30719908

SCHEMBL30719908

CCOC(=O)c1c(C)oc2cnc(OCc3cccnc3C(F)(F)F)cc12

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 6/20 0.50
MAPT P10636 5/20 0.44
LMNA P02545 3/20 0.44
ALDH1A1 P00352 3/20 0.43
HIF1A Q16665 1/20 0.43
TDP1 Q9NUW8 1/20 0.43
MAPK1 P28482 2/20 0.42
TDP2 O95551 3/20 0.41
L3MBTL1 Q9Y468 3/20 0.41
KDM4E B2RXH2 2/20 0.41
TSHR P16473 2/20 0.41
POLB P06746 2/20 0.41
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
NPC1 O15118 1/20 0.40
CYP1A2 P05177 1/20 0.40
CYP3A4 P08684 1/20 0.40
GAA P10253 1/20 0.40
CYP2C9 P11712 1/20 0.40
CYP2C19 P33261 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26699043 1.00 PTGS2 (0.50) PTGS2MAPTLMNAALDH1A1HIF1A
SCHEMBL30719907 1.00 PTGS2 (0.50) PTGS2MAPTLMNAALDH1A1HIF1A
SCHEMBL30719905 0.90 SLC26A4 (0.48) PTGS2LMNATDP1TDP2L3MBTL1
SCHEMBL26699024 0.90 SLC26A4 (0.48) PTGS2LMNATDP1TDP2L3MBTL1
SCHEMBL29095725 0.86 PTGS2 (0.61) PTGS2MAPTLMNAALDH1A1HIF1A
SCHEMBL29630215 0.86 PTGS2 (0.61) PTGS2MAPTLMNAALDH1A1HIF1A
SCHEMBL24485054 0.85 PTGS2 (0.48) PTGS2MAPTLMNAALDH1A1HIF1A
SCHEMBL24484498 0.84 PTGS2 (0.47) PTGS2MAPTLMNAALDH1A1HIF1A
SCHEMBL29630207 0.84 PTGS2 (0.47) PTGS2MAPTLMNAALDH1A1HIF1A
SCHEMBL30719895 0.84 PTGS2 (0.52) PTGS2MAPTLMNAALDH1A1HIF1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4532011-A1 NEW DERIVATIVES FOR TREATING TRPM3 MEDIATED DISORDERS Katholieke Universiteit Leuven KU Leuven Research & Development (BE) 2025-04-09 EP disclosed
WO-2023227698-A1 NEW DERIVATIVES FOR TREATING TRPM3 MEDIATED DISORDERS KATHOLIEKE UNIVERSITEIT LEUVEN (BE) 2023-11-30 WO disclosed